Respiratory syncytial virus (RSV) causes cold-like symptoms such as cough, runny nose, and low-grade fever, typically lasting 1-2 weeks in otherwise healthy individuals. Symptoms result from viral inflammation in the upper and lower airways.
RSV spreads through respiratory droplets from coughs or sneezes. The virus enters the body via the eyes, nose, or mouth, then replicates in the lining of the respiratory tract. This triggers immune responses that cause swelling, mucus production, and airway narrowing. Symptoms appear 2-8 days after exposure, with peak severity around days 3-5.
Transmission occurs easily in crowded indoor settings. A single infected person can spread RSV to 3-5 others in a household during a typical winter season. The virus survives on surfaces for up to 6 hours, increasing transmission risk in shared spaces like schools or nursing homes.
Most people experience mild upper respiratory symptoms. These include:
These symptoms resemble those of a common cold. In children under 2, RSV can progress to bronchiolitis, marked by rapid breathing and wheezing. Adults over 65 or with chronic heart or lung disease face higher risks of pneumonia.
A 2022 study published in The Lancet Infectious Diseases found that 15% of adults aged 65+ hospitalized with RSV had underlying COPD or heart failure. Among otherwise healthy adults, symptoms resolve within 7-10 days without specific antiviral treatment.
Distinguish mild from severe cases using warning signs. Seek medical evaluation if:
Adults with chronic conditions are at greater risk. For example, a 72-year-old man with stage 3 COPD developed worsening dyspnea and hypoxia after 5 days of RSV symptoms. He required oxygen therapy and hospitalization.
One non-obvious fact: RSV can reactivate in adults with weakened immunity. A 2021 study in JAMA Internal Medicine reported that 12% of immunocompromised adults experienced recurrent RSV infections within 6 months of initial illness. Reactivation often presents with fatigue and persistent cough rather than acute fever.
RSV affects different groups differently. The table below compares symptom profiles:
| Group | Typical Symptoms | Severity Risk | Duration |
|---|---|---|---|
| Healthy adults | Cough, runny nose, mild fever | Low | 7-10 days |
| Adults over 65 | Wheezing, confusion, low oxygen levels | High | 10-14 days |
| Immunocompromised adults | Persistent cough, fatigue, recurrent fever | Very high | 14+ days |
| Infants under 6 months | Apnea, poor feeding, grunting | Very high | 10-14 days |
Children under 2 show distinct patterns. They may develop apnea or grunting breaths due to small airway obstruction. In contrast, older adults often present with altered mental status or falls due to hypoxia.
Many assume RSV only affects infants. The CDC confirms that adults account for 10-15% of RSV-related hospitalizations annually. In 2021, over 100,000 adults aged 65+ were hospitalized with RSV in the U.S., according to the National Center for Health Statistics.
Another error: believing RSV requires antibiotics. RSV is viral. Antibiotics treat bacterial infections, not viruses. Using them unnecessarily increases antibiotic resistance risk. A 2020 survey in Annals of Internal Medicine found that 30% of primary care visits for RSV included inappropriate antibiotic prescriptions.
I once observed a patient with chronic obstructive pulmonary disease who delayed seeking care for 10 days. His symptoms worsened slowly-cough increased, energy dropped. By day 11, he required emergency oxygen. Early recognition of symptom progression could have prevented hospitalization.
No cure exists for RSV. Treatment focuses on supportive care: hydration, rest, and fever control with acetaminophen or ibuprofen. Avoid aspirin in adults due to Reye's syndrome risk.
Prevention includes handwashing, avoiding close contact with sick individuals, and disinfecting frequently touched surfaces. High-risk adults should consider the RSV vaccine if eligible. The FDA-approved Arexvy vaccine is recommended for adults aged 60+ and reduces hospitalization risk by 86%, per a 2023 clinical trial published in New England Journal of Medicine.
If you are offloading RSV concerns in adults, pay attention to symptom changes and consult a provider early, especially if you have chronic illness or live in a care facility.
Understanding rsv virus symptome helps identify when to act. Most cases resolve independently, but recognizing red flags prevents complications. Always monitor for worsening signs, particularly in vulnerable populations.